IDXG

$5.44+0.00%visit website

INTERPACE BIOSCIENCES, INC.

Market Cap

$151M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

2.85

27mo monthly vs SPY

P/E (TTM)

6.2

TTM to Jun 2026 · mkt cap / net income

P/S (TTM)

4.2

TTM to Jun 2026 · revenue

P/B

6.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	8,756	9,224	9,032	9,131	36,143
Cost of revenue	3,317	3,180	3,128	3,478	13,103
Gross profit	5,439	6,044	5,904	5,653	23,040
Research & development	150	142	153	149	594
Total operating expenses	4,294	4,467	4,781	5,332	18,874
Operating income	1,145	1,577	1,123	321	4,166
Interest expense	30.0
Pretax income	1,000	1,535	1,133	330	3,998
Income tax	(11)	(21,217)	302	64	(20,862)
Net income	911	22,657	721	158	24,447
EPS (basic) ($)	0.21		0.03	0.01	—
EPS (diluted) ($)	0.03		0.03	0.01	—
Weighted avg. shares (basic)	4,425		22,786	27,701
Weighted avg. shares (diluted)	27,695		27,707	27,713

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 15, 2026 accepted 6:10 AM ET	2.02Earnings release	Document SEC ↗
Aug 27, 2026 accepted 8:30 AM ET	5.03Bylaws / fiscal year7.01Reg FD disclosure	Document SEC ↗
Aug 26, 2026 accepted 10:45 AM ET	8-K/A 5.02Officer / director change	Document SEC ↗
Aug 21, 2026 accepted 6:45 PM ET	5.07Shareholder vote	Document SEC ↗
Aug 12, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
May 14, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
Apr 1, 2026 accepted 4:15 PM ET	2.02Earnings release	Document SEC ↗
Jan 20, 2026 accepted 9:05 AM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Dec 3, 2025 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
Nov 12, 2025 accepted 4:45 PM ET	2.02Earnings release	Document SEC ↗